Digestive Disease Interventions
DOI: 10.1055/s-0044-1786794
Review Article

Plug-Assisted Retrograde Transvenous Obliteration: A Modified Balloon-Occluded Retrograde Transvenous Obliteration of Gastric Varices

Dong Il Gwon
1   Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
,
Hyun-Ki Yoon
1   Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
› Author Affiliations

Abstract

Gastric varices (GVs) and hepatic encephalopathy (HE) are major complications of portal hypertension in patients with liver cirrhosis. As most of the GVs drain into the left renal vein via a portosystemic shunt, the concept of retrograde treatment approach such as balloon-occluded retrograde transvenous obliteration using sclerosing agents has been introduced. Recently, plug-assisted retrograde transvenous obliteration (PARTO) has been alternatively performed, which uses vascular plug and gelfoam. PARTO utilizes a permanent vascular plug to reduce postprocedural monitoring time as well as to avoid the risk of balloon rupture–related complications. It also eliminates the sclerosing agents–related complications with the use of gelfoam as an embolics. In this review, we introduce technical aspects of PARTO and outline its potential for use as the treatment of GVs and HE.



Publication History

Received: 27 February 2024

Accepted: 08 April 2024

Article published online:
15 July 2024

© 2024. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 de Franchis R, Primignani M. Natural history of portal hypertension in patients with cirrhosis. Clin Liver Dis 2001; 5 (03) 645-663
  • 2 Trudeau W, Prindiville T. Endoscopic injection sclerosis in bleeding gastric varices. Gastrointest Endosc 1986; 32 (04) 264-268
  • 3 Uflacker R, Silva AdeO, d'Albuquerque LA, Piske RL, Mourão GS. Chronic portosystemic encephalopathy: embolization of portosystemic shunts. Radiology 1987; 165 (03) 721-725
  • 4 Sarin SK, Lahoti D, Saxena SP, Murthy NS, Makwana UK. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology 1992; 16 (06) 1343-1349
  • 5 Kanagawa H, Mima S, Kouyama H, Gotoh K, Uchida T, Okuda K. Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration. J Gastroenterol Hepatol 1996; 11 (01) 51-58
  • 6 Hirota S, Matsumoto S, Tomita M, Sako M, Kono M. Retrograde transvenous obliteration of gastric varices. Radiology 1999; 211 (02) 349-356
  • 7 Chikamori F, Kuniyoshi N, Shibuya S, Takase Y. Eight years of experience with transjugular retrograde obliteration for gastric varices with gastrorenal shunts. Surgery 2001; 129 (04) 414-420
  • 8 Fukuda T, Hirota S, Sugimura K. Long-term results of balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy. J Vasc Interv Radiol 2001; 12 (03) 327-336
  • 9 Ninoi T, Nishida N, Kaminou T. et al. Balloon-occluded retrograde transvenous obliteration of gastric varices with gastrorenal shunt: long-term follow-up in 78 patients. AJR Am J Roentgenol 2005; 184 (04) 1340-1346
  • 10 Cho SK, Shin SW, Lee IH. et al. Balloon-occluded retrograde transvenous obliteration of gastric varices: outcomes and complications in 49 patients. AJR Am J Roentgenol 2007; 189 (06) W365-72
  • 11 Akahoshi T, Hashizume M, Tomikawa M. et al. Long-term results of balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding and risky gastric varices: a 10-year experience. J Gastroenterol Hepatol 2008; 23 (11) 1702-1709
  • 12 Choi SY, Won JY, Kim KA, Lee DY, Lee KH. Foam sclerotherapy using polidocanol for balloon-occluded retrograde transvenous obliteration (BRTO). Eur Radiol 2011; 21 (01) 122-129
  • 13 Sabri SS, Swee W, Turba UC. et al. Bleeding gastric varices obliteration with balloon-occluded retrograde transvenous obliteration using sodium tetradecyl sulfate foam. J Vasc Interv Radiol 2011; 22 (03) 309-316 , quiz 316
  • 14 Kim MY, Um SH, Baik SK. et al. Clinical features and outcomes of gastric variceal bleeding: retrospective Korean multicenter data. Clin Mol Hepatol 2013; 19 (01) 36-44
  • 15 Chang IS, Park SW, Kwon SY. et al. Efficacy and safety of balloon-occluded retrograde transvenous obliteration with sodium tetradecyl sulfate liquid sclerotherapy. Korean J Radiol 2016; 17 (02) 224-229
  • 16 Imai Y, Nakazawa M, Ando S, Sugawara K, Mochida S. Long-term outcome of 154 patients receiving balloon-occluded retrograde transvenous obliteration for gastric fundal varices. J Gastroenterol Hepatol 2016; 31 (11) 1844-1850
  • 17 Kumamoto M, Toyonaga A, Inoue H. et al. Long-term results of balloon-occluded retrograde transvenous obliteration for gastric fundal varices: hepatic deterioration links to portosystemic shunt syndrome. J Gastroenterol Hepatol 2010; 25 (06) 1129-1135
  • 18 Chu HH, Kim M, Kim HC, Lee JH, Jae HJ, Chung JW. Long-term outcomes of balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices: a comparison of ethanolamine oleate and sodium tetradecyl sulfate. Cardiovasc Intervent Radiol 2018; 41 (04) 578-586
  • 19 Yokoyama K, Yamauchi R, Shibata K. et al. Endoscopic treatment or balloon-occluded retrograde transvenous obliteration is safe for patients with esophageal/gastric varices in Child-Pugh class C end-stage liver cirrhosis. Clin Mol Hepatol 2019; 25 (02) 183-189
  • 20 Mukund A, Rangarh P, Shasthry SM, Patidar Y, Sarin SK. Salvage balloon occluded retrograde transvenous obliteration for gastric variceal bleed in cirrhotic patients with endoscopic failure to control bleed/very early rebleed: long-term outcomes. J Clin Exp Hepatol 2020; 10 (05) 421-428
  • 21 Mukund A, Chalamarla LK, Singla N, Shasthry SM, Sarin SK. Intractable hepatic encephalopathy in cirrhotic patients: mid-term efficacy of balloon-occluded retrograde portosystemic shunt obliteration. Eur Radiol 2020; 30 (06) 3462-3472
  • 22 Lee EW, Saab S, Kaldas F. et al. Coil-assisted retrograde transvenous obliteration (CARTO): an alternative treatment option for refractory hepatic encephalopathy. Am J Gastroenterol 2018; 113 (08) 1187-1196
  • 23 Gwon DI, Ko GY, Yoon HK. et al. Gastric varices and hepatic encephalopathy: treatment with vascular plug and gelatin sponge-assisted retrograde transvenous obliteration – a primary report. Radiology 2013; 268 (01) 281-287
  • 24 Gwon DI, Kim YH, Ko GY. et al. Vascular plug-assisted retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy: a prospective multicenter study. J Vasc Interv Radiol 2015; 26 (11) 1589-1595
  • 25 Gwon DI, Ko GY, Kwon YB, Yoon HK, Sung KB. Plug-assisted retrograde transvenous obliteration for the treatment of gastric varices: the role of intra-procedural cone-beam computed tomography. Korean J Radiol 2018; 19 (02) 223-229
  • 26 Chang MY, Kim MD, Kim T. et al. Plug-assisted retrograde transvenous obliteration for the treatment of gastric variceal hemorrhage. Korean J Radiol 2016; 17 (02) 230-238
  • 27 Kim T, Yang H, Lee CK, Kim GB. Vascular plug assisted retrograde transvenous obliteration (PARTO) for gastric varix bleeding patients in the emergent clinical setting. Yonsei Med J 2016; 57 (04) 973-979
  • 28 Park JW, Yoo JJ, Kim SG. et al. Change in portal pressure and clinical outcome in cirrhotic patients with gastric varices after plug-assisted retrograde transvenous obliteration. Gut Liver 2020; 14 (06) 783-791
  • 29 Kim YH, Kim YH, Kim CS, Kang UR, Kim SH, Kim JH. Comparison of balloon-occluded retrograde transvenous obliteration (BRTO) using ethanolamine oleate (EO), BRTO using sodium tetradecyl sulfate (STS) foam and vascular plug-assisted retrograde transvenous obliteration (PARTO). Cardiovasc Intervent Radiol 2016; 39 (06) 840-846
  • 30 de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C. Baveno VII Faculty. Baveno VII - renewing consensus in portal hypertension. J Hepatol 2022; 76 (04) 959-974
  • 31 Henry Z, Patel K, Patton H, Saad W. AGA clinical practice update on management of bleeding gastric varices: expert review. Clin Gastroenterol Hepatol 2021; 19 (06) 1098-1107.e1
  • 32 Choe JW, Yim HJ, Lee SH. et al. Primary prophylaxis of gastric variceal bleeding: endoscopic obturation, radiologic intervention, or observation?. Hepatol Int 2021; 15 (04) 934-945
  • 33 Wang W, Li H, Tam MD, Zhou D, Wang DX, Spain J. The Amplatzer vascular plug: a review of the device and its clinical applications. Cardiovasc Intervent Radiol 2012; 35 (04) 725-740
  • 34 Lopera JE. The Amplatzer vascular plug: review of evolution and current applications. Semin Intervent Radiol 2015; 32 (04) 356-369
  • 35 Rossi M, Rebonato A, Greco L. et al. A new device for vascular embolization: report on case of two pulmonary arteriovenous fistulas embolization using the Amplatzer vascular plug. Cardiovasc Intervent Radiol 2006; 29 (05) 902-906
  • 36 Yoo H, Ko GY, Gwon DI. et al. Preoperative portal vein embolization using an Amplatzer vascular plug. Eur Radiol 2009; 19 (05) 1054-1061
  • 37 Luo X, Xiang T, Wu J. et al. Endoscopic cyanoacrylate injection versus balloon-occluded retrograde transvenous obliteration for prevention of gastric variceal bleeding: a randomized controlled trial. Hepatology 2021; 74 (04) 2074-2084